Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock
Portfolio Pulse from
Calidi Biotherapeutics, Inc. has announced the pricing of its public offering of 5,000,000 shares of common stock at $0.85 per share, raising $4.25 million.
January 10, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Calidi Biotherapeutics has priced its public offering of 5 million shares at $0.85 per share, raising $4.25 million. This move could impact the stock price due to dilution and market perception.
The public offering increases the number of shares outstanding, which can lead to dilution of existing shares. The offering price of $0.85 may also influence market perception, potentially leading to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100